Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2022

Open Access 01-12-2022 | Review

Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries

Authors: George D. Bittner, Jared S. Bushman, Cameron L. Ghergherehchi, Kelly C. S. Roballo, Jaimie T. Shores, Tyler A. Smith

Published in: Journal of Neuroinflammation | Issue 1/2022

Login to get access

Abstract

We review data showing that peripheral nerve injuries (PNIs) that involve the loss of a nerve segment are the most common type of traumatic injury to nervous systems. Segmental-loss PNIs have a poor prognosis compared to other injuries, especially when one or more mixed motor/sensory nerves are involved and are typically the major source of disability associated with extremities that have sustained other injuries. Relatively little progress has been made, since the treatment of segmental loss PNIs with cable autografts that are currently the gold standard for repair has slow and incomplete (often non-existent) functional recovery. Viable peripheral nerve allografts (PNAs) to repair segmental-loss PNIs have not been experimentally or clinically useful due to their immunological rejection, Wallerian degeneration (WD) of anucleate donor graft and distal host axons, and slow regeneration of host axons, leading to delayed re-innervation and producing atrophy or degeneration of distal target tissues. However, two significant advances have recently been made using viable PNAs to repair segmental-loss PNIs: (1) hydrogel release of Treg cells that reduce the immunological response and (2) PEG-fusion of donor PNAs that reduce the immune response, reduce and/or suppress much WD, immediately restore axonal conduction across the donor graft and re-innervate many target tissues, and restore much voluntary behavioral functions within weeks, sometimes to levels approaching that of uninjured nerves. We review the rather sparse cellular/biochemical data for rejection of conventional PNAs and their acceptance following Treg hydrogel and PEG-fusion of PNAs, as well as cellular and systemic data for their acceptance and remarkable behavioral recovery in the absence of tissue matching or immune suppression. We also review typical and atypical characteristics of PNAs compared with other types of tissue or organ allografts, problems and potential solutions for PNA use and storage, clinical implications and commercial availability of PNAs, and future possibilities for PNAs to repair segmental-loss PNIs.
Literature
1.
2.
Campbell WW. Evaluation and management of peripheral nerve injury. Clin Neurophysiol. 2008;119:1951–65.PubMedCrossRef
3.
Bittner GD, Sengelaub DR, Trevino RC, Peduzzi JD, Mikesh M, Ghergherehchi CK, Schallert T, Thayer WP. The curious ability of PEG-fusion technologies to restore lost behaviors after nerve severance. J Neurosci Res. 2016;94:207–30.PubMedCrossRef
4.
Mikesh M, Ghergherehchi CL, Rahesh S, Jagannath K, Ali A, Sengelaub DR, Trevino RC, Jackson DM, Tucker HO, Bittner GD. Polyethylene glycol treated allografts not tissue matched nor immunosuppressed rapidly repair sciatic nerve gaps, maintain neuromuscular functions, and restore voluntary behaviors in female rats. J Neurosci Res. 2018;96:1243–64.PubMedPubMedCentralCrossRef
5.
Lad SP, Nathan JK, Schubert RD, Boakye M. Trends in median, ulnar, radial, and brachioplexus nerve injuries in the United States. Neurosurgery. 2010;66:953–60.PubMedCrossRef
6.
Roballo KCS, Gigley JP, Smith TA, Bittner GD, Bushman JS. Morphological, functional, and immunological peculiarities of peripheral nerve allografts. Nerve Regen Res. 2021;17(4):721.
7.
Mikesh M, Ghergherehchi CL, Hastings RL, Ali A, Rahesh S, Jagannath K, Sengelaub DR, Trevino RC, Jackson DM, Bittner GD. Polyethylene glycol solutions rapidly restore and maintain axonal continuity, neuromuscular structures, and behaviors lost after sciatic nerve transections in female rats. J Neurosci Res. 2018;96:1223–42.PubMedPubMedCentralCrossRef
8.
9.
Ijkema-Paassen J, Meek MF, Gramsbergen A. Reinnervation of muscles after transection of the sciatic nerve in adult rats. Muscle Nerve. 2002;25:891–7.PubMedCrossRef
10.
11.
Jonsson S, Wiberg R, McGrath AM, Novikov LN, Wiberg M, Novikova LN, Kingham PJ. Effect of delayed peripheral nerve repair on nerve regeneration, Schwann cell function and target muscle recovery. PLoS ONE. 2013;8:e56484.PubMedPubMedCentralCrossRef
12.
Murphy K, Weaver C. Janeway’s immunobiology. 9th ed. New York: Garland Science/Taylor & Francis Group LLC; 2017.
13.
Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol. 2010;6:155–69.PubMedCrossRef
14.
Smith TA, Ghergherehchi CL, Tucker HO, Bittner GD. Coding transcriptome analyses reveal altered functions underlying immunotolerance of PEG-fused rat sciatic nerve allografts. J Neuroinflammation. 2020;17:287.PubMedPubMedCentralCrossRef
15.
Smith TA, Ghergherehchi CL, Mikesh M, Shores JT, Tucker HO, Bittner GD. Polyethylene glycol-fusion repair of sciatic allografts in female rats achieves immunotolerance via attenuated innate and adaptive responses. J Neurosci Res. 2020;98:2468–95.PubMedCrossRef
16.
Converse JM, Smahel J, Ballantyne DL, Harper AD. Inosculation of vessels of skin graft and host bed: a fortuitous encounter. Br J Plast Surg. 1975;28:274–82.PubMedCrossRef
17.
Laschke MW, Vollmar B, Menger MD. Inosculation: connecting the life-sustaining pipelines. Tissue Eng Part B Rev. 2009;15:455–65.PubMedCrossRef
18.
Converse JM, Uhlschmid GK, Ballantyne DL. “Plasmatic circulation” in skin grafts. The phase of serum imbibition. Plast Reconstr Surg. 1969;43:495–9.PubMedCrossRef
19.
Marshall DC, Freidman EA, Goldstein DP, Henry L, Merrill JP. Clinical criteria for evaluating first set, accelerated, and white graft rejection in human skin homografts. Surg Forum. 1961;12:469–70.PubMed
20.
Antibody production and skin graft rejection. Nature 238:16 (1972)
21.
22.
Acevedo DC, Shore B, Mirzayan R. Orthopedic applications of acellular human dermal allograft for shoulder and elbow surgery. Orthop Clin N Am. 2015;46(377–388):x.
23.
Chiarello E, Cadossi M, Tedesco G, Capra P, Calamelli C, Shehu A, Giannini S. Autograft, allograft and bone substitutes in reconstructive orthopedic surgery. Aging Clin Exp Res. 2013;25(Suppl 1):S101-103.PubMedCrossRef
24.
25.
Hartzell TL, Benhaim P, Imbriglia JE, Shores JT, Goitz RJ, Balk M, Mitchell S, Rubinstein R, Gorantla VS, Schneeberger S, et al. Surgical and technical aspects of hand transplantation: is it just another replant? Hand Clin. 2011;27(521–530):x.
26.
Azari KK, Imbriglia JE, Goitz RJ, Shores JT, Balk ML, Brandacher G, Schneeberger S, Gorantla V, Lee WP. Technical aspects of the recipient operation in hand transplantation. J Reconstr Microsurg. 2012;28:27–34.PubMedCrossRef
27.
Elkwood AI, Holland NR, Arbes SM, Rose MI, Kaufman MR, Ashinoff RL, Parikh MA, Patel TR. Nerve allograft transplantation for functional restoration of the upper extremity: case series. J Spinal Cord Med. 2011;34:241–7.PubMedPubMedCentralCrossRef
28.
Larsen M, Habermann TM, Bishop AT, Shin AY, Spinner RJ. Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case report. J Neurosurg. 2007;106:924–8.PubMedCrossRef
29.
Bittner G, Schallert T, Peduzzi J. Degeneration, trophic interactions, and repair of severed axons: a reconsideration of some common assumptions. Neuroscientist. 2000;6:88–109.CrossRef
30.
Bittner GD, Sengelaub DR, Trevino RC, Peduzzi JD, Mikesh M, Ghergherehchi CL, Schallert T, Thayer WP. The curious ability of polyethylene glycol fusion technologies to restore lost behaviors after nerve severance. J Neurosci Res. 2016;94:207–30.PubMedCrossRef
31.
Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg. 2001;107:1419–29.PubMedCrossRef
32.
Ghergherehchi CL, Hibbard EA, Mikesh M, Bittner GD, Sengelaub DR. Behavioral recovery and spinal motoneuron remodeling after polyethylene glycol fusion repair of singly cut and ablated sciatic nerves. PLoS ONE. 2019;14:e0223443.PubMedPubMedCentralCrossRef
33.
Ghergherehchi CL, Mikesh M, Sengelaub DR, Jackson DM, Smith T, Nguyen J, Shores JT, Bittner GD. Polyethylene glycol (PEG) and other bioactive solutions with neurorrhaphy for rapid and dramatic repair of peripheral nerve lesions by PEG-fusion. J Neurosci Methods. 2019;314:1–12.PubMedCrossRef
34.
Evans PJ, Midha R, Mackinnon SE. The peripheral nerve allograft: a comprehensive review of regeneration and neuroimmunology. Prog Neurobiol. 1994;43:187–233.PubMedCrossRef
35.
36.
Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res. 2009;43:25–61.PubMedCrossRef
37.
Land WG. Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury. Transpl Rev (Orlando). 2012;26:60–72.CrossRef
38.
39.
40.
Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG, Shlomchik MJ, Kaplan DH. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol. 2008;128:1950–5.PubMedPubMedCentralCrossRef
41.
Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Int Immunol. 2008;20:1343–9.PubMedCrossRef
42.
Auchincloss H, Mayer T, Ghobrial R, Winn HJ. T-cell subsets, bm mutants, and the mechanisms of allogenic skin graft rejection. Immunol Res. 1989;8:149–64.PubMedCrossRef
43.
44.
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50.PubMedPubMedCentralCrossRef
45.
Evans PJ, Mackinnon SE, Levi AD, Wade JA, Hunter DA, Nakao Y, Midha R. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve. 1998;21:1507–22.PubMedCrossRef
46.
Roballo KCS, Bushman J. Evaluation of the host immune response and functional recovery in peripheral nerve autografts and allografts. Transpl Immunol. 2019;53:61–71.PubMedCrossRef
47.
Nichols CM, Brenner MJ, Fox IK, Tung TH, Hunter DA, Rickman SR, Mackinnon SE. Effects of motor versus sensory nerve grafts on peripheral nerve regeneration. Exp Neurol. 2004;190:347–55.PubMedCrossRef
48.
Moradzadeh A, Borschel GH, Luciano JP, Whitlock EL, Hayashi A, Hunter DA, Mackinnon SE. The impact of motor and sensory nerve architecture on nerve regeneration. Exp Neurol. 2008;212:370–6.PubMedPubMedCentralCrossRef
49.
Brenner MJ, Hess JR, Myckatyn TM, Hayashi A, Hunter DA, Mackinnon SE. Repair of motor nerve gaps with sensory nerve inhibits regeneration in rats. Laryngoscope. 2006;116:1685–92.PubMedCrossRef
50.
51.
Webber C, Zochodne D. The nerve regenerative microenvironment: early behavior and partnership of axons and Schwann cells. Exp Neurol. 2010;223:51–9.PubMedCrossRef
52.
Dalamagkas K, Tsintou M, Seifalian A. Advances in peripheral nervous system regenerative therapeutic strategies: a biomaterials approach. Mater Sci Eng C Mater Biol Appl. 2016;65:425–32.PubMedCrossRef
53.
Jones S, Eisenberg HM, Jia X. Advances and future applications of augmented peripheral nerve regeneration. Int J Mol Sci. 2016;17:1494.PubMedCentralCrossRef
54.
Willand MP, Nguyen MA, Borschel GH, Gordon T. Electrical stimulation to promote peripheral nerve regeneration. Neurorehabil Neural Repair. 2016;30:490–6.PubMedCrossRef
55.
Kataria H, Lutz D, Chaudhary H, Schachner M, Loers G. Small molecule agonists of cell adhesion molecule L1 mimic L1 functions in vivo. Mol Neurobiol. 2016;53:4461–83.PubMedCrossRef
56.
Fairbairn NG, Meppelink AM, Ng-Glazier J, Randolph MA, Winograd JM. Augmenting peripheral nerve regeneration using stem cells: a review of current opinion. World J Stem Cells. 2015;7:11–26.PubMedPubMedCentralCrossRef
57.
Ghergherehchi CL, Shores JT, Alderete J, Weitzel EK, Bittner GD. Methylene blue enhances polyethylene glycol-fusion repair of completely severed rat sciatic nerves. Neural Regen Res. 2021;16:2056–63.PubMedPubMedCentralCrossRef
58.
59.
Liu P, Peng J, Han GH, Ding X, Wei S, Gao G, Huang K, Chang F, Wang Y. Role of macrophages in peripheral nerve injury and repair. Neural Regen Res. 2019;14:1335–42.PubMedPubMedCentralCrossRef
60.
Tomlinson JE, Žygelytė E, Grenier JK, Edwards MG, Cheetham J. Temporal changes in macrophage phenotype after peripheral nerve injury. J Neuroinflammation. 2018;15:185.PubMedPubMedCentralCrossRef
61.
Richard L, Védrenne N, Vallat JM, Funalot B. Characterization of endoneurial fibroblast-like cells from human and rat peripheral nerves. J Histochem Cytochem. 2014;62:424–35.PubMedPubMedCentralCrossRef
62.
Fornasari BE, El Soury M, Nato G, Fucini A, Carta G, Ronchi G, Crosio A, Perroteau I, Geuna S, Raimondo S, Gambarotta G. Fibroblasts colonizing nerve conduits express high levels of soluble neuregulin1, a factor promoting schwann cell dedifferentiation. Cells. 2020;9:1366.PubMedCentralCrossRef
63.
Dreesmann L, Mittnacht U, Lietz M, Schlosshauer B. Nerve fibroblast impact on Schwann cell behavior. Eur J Cell Biol. 2009;88:285–300.PubMedCrossRef
64.
Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. Biomed Res Int. 2014;14:698256.
65.
Sawyer JT, Akeson RA. Clonal myoblasts and myotubes show differences in lectin-binding patterns. Exp Cell Res. 1983;145:1–13.PubMedCrossRef
66.
Riley DC, Bittner GD, Mikesh M, Cardwell NL, Pollins AC, Ghergherehchi CL, Bhupanapadu Sunkesula SR, Ha TN, Hall BT, Poon AD, et al. Polyethylene glycol-fused allografts produce rapid behavioral recovery after ablation of sciatic nerve segments. J Neurosci Res. 2015;93:572–83.PubMedCrossRef
67.
Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH, Negrin RS. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106:1113–22.PubMedPubMedCentralCrossRef
68.
Karanth S, Yang G, Yeh J, Richardson PM. Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp Neurol. 2006;202:161–6.PubMedCrossRef
69.
DeFrancesco-Lisowitz A, Lindborg JA, Niemi JP, Zigmond RE. The neuroimmunology of degeneration and regeneration in the peripheral nervous system. Neuroscience. 2015;302:174–203.PubMedCrossRef
70.
Kandel E, Schwartz J, Jessell T, Siegelbaum S, Hudspeth A, Mack S. Principals of neuroscience. 6th ed. New York: McGraw; 2018.
71.
Gaudet AD, Popovich PG, Ramer MS. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation. 2011;8:110.PubMedPubMedCentralCrossRef
72.
Lisak RP, Bealmear B, Benjamins JA. Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1. J Neuroimmunol. 2016;295–296:93–9.PubMedCrossRef
73.
Tomlinson JE, Zygelyte E, Grenier JK, Edwards MG, Cheetham J. Temporal changes in macrophage phenotype after peripheral nerve injury. J Neuroinflammation. 2018;15:185.PubMedPubMedCentralCrossRef
74.
Richard L, Vedrenne N, Vallat JM, Funalot B. Characterization of endoneurial fibroblast-like cells from human and rat peripheral nerves. J Histochem Cytochem. 2014;62:424–35.PubMedPubMedCentralCrossRef
75.
Kim MJ, Kim HS, Kim SC, Kwak YS. Complete Genome Sequence of Lanthionine-Producing Lactobacillus brevis Strain 100D8, Generated by PacBio Sequencing. Microbiol Resour Announc. 2018;7(14):e01220-e1318.PubMedPubMedCentralCrossRef
76.
Lindahl KF, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro. J Exp Med. 1977;145:500–7.PubMedCrossRef
77.
Colf LA, Bankovich AJ, Hanick NA, Bowerman NA, Jones LL, Kranz DM, Garcia KC. How a single T cell receptor recognizes both self and foreign MHC. Cell. 2007;129:135–46.PubMedCrossRef
78.
Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, Bharadwaj M, Kjer-Nielsen L, Saunders PM, Wilce MC, et al. T cell allorecognition via molecular mimicry. Immunity. 2009;31:897–908.PubMedCrossRef
79.
Sprent J, Schaefer M. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. J Exp Med. 1985;162:2068–88.PubMedCrossRef
80.
Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995;269:1588–90.PubMedCrossRef
81.
82.
83.
Maiuolo J, Gliozzi M, Musolino V, Carresi C, Nucera S, Macrì R, Scicchitano M, Bosco F, Scarano F, Ruga S, et al. The role of endothelial dysfunction in peripheral blood nerve barrier: molecular mechanisms and pathophysiological implications. Int J Mol Sci. 2019;20:3022.PubMedCentralCrossRef
84.
85.
86.
Trumble TE, Gunlikson R, Parvin D. Systemic immune response to peripheral nerve transplants across major histocompatibility class-I and class-II barriers. J Orthop Res. 1994;12:844–52.PubMedCrossRef
87.
Bijen HM, Hassan C, Kester MGD, Janssen GMC, Hombrink P, de Ru AH, Drijfhout JW, Meiring HD, de Jong AP, Falkenburg JHF, et al. Specific T cell responses against minor histocompatibility antigens cannot generally be explained by absence of their allelic counterparts on the cell surface. Proteomics. 2018;18:e1700250.PubMedCrossRef
88.
Liu W, Ren Y, Bossert A, Wang X, Dayawansa S, Tong J, He X, Smith DH, Gelbard HA, Huang JH. Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity. PLoS ONE. 2012;7:e31675.PubMedPubMedCentralCrossRef
89.
Roberts MB, Fishman JA. Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression.” Clin Infect Dis. 2020;73:e1302–17.PubMedCentralCrossRef
90.
91.
Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep. 2000;1:428–34.PubMedPubMedCentralCrossRef
92.
Midha R, Evans PJ, Mackinnon SE, Wade JA. Temporary immunosuppression for peripheral nerve allografts. Transpl Proc. 1993;25:532–6.
93.
Santos Roballo KC, Dhungana S, Jiang Z, Oakey J, Bushman JS. Localized delivery of immunosuppressive regulatory T cells to peripheral nerve allografts promotes regeneration of branched segmental defects. Biomaterials. 2019;209:1–9.PubMedCrossRef
94.
Matsuyama T, Midha R, Mackinnon SE, Munro CA, Wong PY, Ang LC. Long nerve allografts in sheep with cyclosporin A immunosuppression. J Reconstr Microsurg. 2000;16:219–25.PubMedCrossRef
95.
Fishman JA. Infection in organ transplantation. Am J Transpl. 2017;17:856–79.CrossRef
96.
Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891–901.PubMedPubMedCentralCrossRef
97.
Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol. 2003;23:465–76.PubMedCrossRef
98.
99.
100.
101.
Atchabahian A, Doolabh VB, Mackinnon SE, Yu S, Hunter DA, Flye MW. Indefinite survival of peripheral nerve allografts after temporary cyclosporine A immunosuppression. Restor Neurol Neurosci. 1998;13:129–39.PubMed
102.
Safinia N, Scotta C, Vaikunthanathan T, Lechler RI, Lombardi G. Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation. Front Immunol. 2015;6:438.PubMedPubMedCentralCrossRef
103.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.PubMed
104.
Mathew JM, LeFever A, Konieczna I, Stratton C, He J, Huang X, Gallon L, Skaro A, Ansari MJ, Leventhal JR. A phase I clinical trial with ex vivo expanded recipient regulatory t cells in living donor kidney transplants. Sci Rep. 2018;8:7428.PubMedPubMedCentralCrossRef
105.
van der Net JB, Bushell A, Wood KJ, Harden PN. Regulatory T cells: first steps of clinical application in solid organ transplantation. Transpl Int. 2016;29:3–11.PubMedCrossRef
106.
107.
108.
109.
110.
Zhang X, Xin N, Tong L, Tong XJ. Electrical stimulation enhances peripheral nerve regeneration after crush injury in rats. Mol Med Rep. 2013;7:1523–7.PubMedCrossRef
111.
112.
Lore AB, Hubbell JA, Bobb DS, Ballinger ML, Loftin KL, Smith JW, Smyers ME, Garcia HD, Bittner GD. Rapid induction of functional and morphological continuity between severed ends of mammalian or earthworm myelinated axons. J Neurosci. 1999;19:2442–54.PubMedPubMedCentralCrossRef
113.
Marzullo TC, Britt JM, Stavisky RC, Bittner GD. Cooling enhances in vitro survival and fusion-repair of severed axons taken from the peripheral and central nervous systems of rats. Neurosci Lett. 2002;327:9–12.PubMedCrossRef
114.
Britt JM, Kane JR, Spaeth CS, Zuzek A, Robinson GL, Gbanaglo MY, Estler CJ, Boydston EA, Schallert T, Bittner GD. Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after sciatic nerve crush injury. J Neurophysiol. 2010;104:695–703.PubMedCrossRef
115.
Bamba R, Waitayawinyu T, Nookala R, Riley DC, Boyer RB, Sexton KW, Boonyasirikool C, Niempoog S, Kelm ND, Does MD, et al. A novel therapy to promote axonal fusion in human digital nerves. J Trauma Acute Care Surg. 2016;81:S177–83.PubMedPubMedCentralCrossRef
116.
Bittner GD, Keating CP, Kane JR, Britt JM, Spaeth CS, Fan JD, Zuzek A, Wilcott RW, Thayer WP, Winograd JM, et al. Rapid, effective, and long-lasting behavioral recovery produced by microsutures, methylene blue, and polyethylene glycol after completely cutting rat sciatic nerves. J Neurosci Res. 2012;90:967–80.PubMedCrossRef
117.
Krakauer JW, Ghazanfar AA, Gomez-Marin A, MacIver MA, Poeppel D. Neuroscience needs behavior: correcting a reductionist bias. Neuron. 2017;93:480–90.PubMedCrossRef
118.
Baker RE, Matesz K, Corner MA, Székely G. Peripheral reinnervation patterns and dorsal root ganglion topography in skin-grafted frogs: a behavioral and histological examination. Dev Neurosci. 1981;4:134–41.PubMedCrossRef
119.
Ghergherehchi CL, Bittner GD, Hastings RL, Mikesh M, Riley DC, Trevino RC, Schallert T, Thayer WP, Bhupanapadu Sunkesula SR, Ha TA, et al. Effects of extracellular calcium and surgical techniques on restoration of axonal continuity by polyethylene glycol fusion following complete cut or crush severance of rat sciatic nerves. J Neurosci Res. 2016;94:231–45.PubMedPubMedCentralCrossRef
120.
Mitsuhashi N, Wu GD, Zhu H, Kearns-Jonker M, Cramer DV, Starnes VA, Barr ML. Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models. Mol Cell Biochem. 2007;296:1–9.PubMedCrossRef
121.
Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163–89.PubMedCrossRef
122.
Wojno T. Commentary on: “Dynamic canthopexy” drill hole canthal repositioning. Aesthet Surg J. 2019;39:1295–6.PubMedCrossRef
123.
124.
125.
Tait Wojno ED, Hunter CA, Stumhofer JS. the immunobiology of the interleukin-12 family: room for discovery. Immunity. 2019;50:851–70.PubMedCrossRef
126.
127.
Allison TL. Immunosuppressive therapy in transplantation. Nurs Clin N Am. 2016;51:107–20.CrossRef
128.
Di Maira T, Little EC, Berenguer M. Immunosuppression in liver transplant. Best Pract Res Clin Gastroenterol. 2020;46:101681.PubMedCrossRef
129.
Nadeau S, Filali M, Zhang J, Kerr BJ, Rivest S, Soulet D, Iwakura Y, de Rivero Vaccari JP, Keane RW, Lacroix S. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1β and TNF: implications for neuropathic pain. J Neurosci. 2011;31:12533–42.PubMedPubMedCentralCrossRef
130.
Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 2019;10:1084.PubMedPubMedCentralCrossRef
131.
Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166–73.PubMedCrossRef
132.
133.
Choy JC. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ. 2010;17:567–76.PubMedCrossRef
134.
Goping IS, Barry M, Liston P, Sawchuk T, Constantinescu G, Michalak KM, Shostak I, Roberts DL, Hunter AM, Korneluk R, Bleackley RC. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity. 2003;18:355–65.PubMedCrossRef
135.
Zheng TS, Schlosser SF, Dao T, Hingorani R, Crispe IN, Boyer JL, Flavell RA. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc Natl Acad Sci USA. 1998;95:13618–23.PubMedPubMedCentralCrossRef
136.
Pieper GM, Nilakantan V, Nguyen TK, Hilton G, Roza AM, Johnson CP. Reactive oxygen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant rejection. Antioxid Redox Signal. 2008;10:1031–40.PubMedPubMedCentralCrossRef
137.
Androlewicz MJ, Ortmann B, van Endert PM, Spies T, Cresswell P. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc Natl Acad Sci USA. 1994;91:12716–20.PubMedPubMedCentralCrossRef
138.
Ludigs K, Seguín-Estévez Q, Lemeille S, Ferrero I, Rota G, Chelbi S, Mattmann C, MacDonald HR, Reith W, Guarda G. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. PLoS Genet. 2015;11:e1005088.PubMedPubMedCentralCrossRef
139.
Masternak K, Muhlethaler-Mottet A, Villard J, Zufferey M, Steimle V, Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 2000;14:1156–66.PubMedPubMedCentralCrossRef
140.
Thuillier R, Giraud S, Favreau F, Goujon JM, Desurmont T, Eugene M, Barrou B, Hauet T. Improving long-term outcome in allograft transplantation: role of ionic composition and polyethylene glycol. Transplantation. 2011;91:605–14.PubMedCrossRef
141.
Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbæk MS, Simões AMC, Roslind A, Engelholm LH, Noessner E, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7:68.PubMedPubMedCentralCrossRef
142.
McWhorter FY, Davis CT, Liu WF. Physical and mechanical regulation of macrophage phenotype and function. Cell Mol Life Sci. 2015;72:1303–16.PubMedCrossRef
143.
Oltean M, Joshi M, Björkman E, Oltean S, Casselbrant A, Herlenius G, Olausson M. Intraluminal polyethylene glycol stabilizes tight junctions and improves intestinal preservation in the rat. Am J Transpl. 2012;12:2044–51.CrossRef
144.
Schaefer A, Hordijk PL. Cell-stiffness-induced mechanosignaling - a key driver of leukocyte transendothelial migration. J Cell Sci. 2015;128:2221–30.PubMedCrossRef
145.
146.
Brenner MJ, Tung TH, Jensen JN, Mackinnon SE. The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Jt Surg Am. 2002;84:1861–70.CrossRef
147.
Kim JP, Hundepool CA, Friedrich PF, Moran SL, Bishop AT, Shin AY. The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model. Microsurgery. 2018;38:66–75.PubMedCrossRef
148.
Büttemeyer R, Rao U, Jones NF. Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. Ann Plast Surg. 1995;35:396–401.PubMedCrossRef
149.
Stefănescu O, Jecan R, Bădoiu S, Enescu DM, Lascăr I. Peripheral nerve allograft, a reconstructive solution: outcomes and benefits. Chirurgia (Bucur). 2012;107:438–41.
150.
Ives GC, Kung TA, Nghiem BT, Ursu DC, Brown DL, Cederna PS, Kemp SWP. Current state of the surgical treatment of terminal neuromas. Neurosurgery. 2018;83:354–64.PubMedCrossRef
151.
Economides JM, DeFazio MV, Attinger CE, Barbour JR. Prevention of painful neuroma and phantom limb pain after transfemoral amputations through concomitant nerve coaptation and collagen nerve wrapping. Neurosurgery. 2016;79:508–13.PubMedCrossRef
152.
Watson J, Gonzalez M, Romero A, Kerns J. Neuromas of the hand and upper extremity. J Hand Surg Am. 2010;35:499–510.PubMedCrossRef
153.
Zhai Q, Wang J, Kim A, Liu Q, Watts R, Hoopfer E, Mitchison T, Luo L, He Z. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron. 2003;39:217–25.PubMedCrossRef
154.
Sunio A, Bittner GD. Cyclosporin A retards the wallerian degeneration of peripheral mammalian axons. Exp Neurol. 1997;146:46–56.PubMedCrossRef
155.
Sea T, Ballinger ML, Bittner GD. Cooling of peripheral myelinated axons retards Wallerian degeneration. Exp Neurol. 1995;133:85–95.PubMedCrossRef
156.
Wakatsuki S, Furuno A, Ohshima M, Araki T. Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration. J Cell Biol. 2015;211:881–96.PubMedPubMedCentralCrossRef
157.
Calliari A, Bobba N, Escande C, Chini EN. Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner. Exp Neurol. 2014;251:91–100.PubMedCrossRef
158.
De S, Trigueros MA, Kalyvas A, David S. Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci. 2003;24:753–65.PubMedCrossRef
159.
Ma M, Ferguson TA, Schoch KM, Li J, Qian Y, Shofer FS, Saatman KE, Neumar RW. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration. Neurobiol Dis. 2013;56:34–46.PubMedPubMedCentralCrossRef
160.
Ikeguchi R, Kakinoki R, Matsumoto T, Yamakawa T, Nakayama K, Morimoto Y, Nakamura T. Successful storage of peripheral nerves using University of Wisconsin solution with polyphenol. J Neurosci Methods. 2007;159:57–65.PubMedCrossRef
161.
162.
Rivera JC, Glebus GP, Cho MS. Disability following combat-sustained nerve injury of the upper limb. Bone Jt J. 2014;96:254–8.CrossRef
163.
Novak CB, Anastakis DJ, Beaton DE, Mackinnon SE, Katz J. Relationships among pain disability, pain intensity, illness intrusiveness, and upper extremity disability in patients with traumatic peripheral nerve injury. J Hand Surg Am. 2010;35:1633–9.PubMedCrossRef
164.
Novak CB, Anastakis DJ, Beaton DE, Mackinnon SE, Katz J. Biomedical and psychosocial factors associated with disability after peripheral nerve injury. J Bone Jt Surg Am. 2011;93:929–36.CrossRef
165.
Noble J, Munro CA, Prasad VS, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma. 1998;45:116–22.PubMedCrossRef
166.
Novak CB, Anastakis DJ, Beaton DE, Katz J. Patient-reported outcome after peripheral nerve injury. J Hand Surg Am. 2009;34:281–7.PubMedCrossRef
167.
168.
Meena P, Kakkar A, Kumar M, Khatri N, Nagar RK, Singh A, Malhotra P, Shukla M, Saraswat SK, Srivastava S, et al. Advances and clinical challenges for translating nerve conduit technology from bench to bed side for peripheral nerve repair. Cell Tissue Res. 2021;383:617–44.PubMedCrossRef
169.
Raza C, Riaz HA, Anjum R, Shakeel NUA. Repair strategies for injured peripheral nerve: review. Life Sci. 2020;243:117308.PubMedCrossRef
170.
Carvalho CR, Oliveira JM, Reis RL. Modern trends for peripheral nerve repair and regeneration: beyond the hollow nerve guidance conduit. Front Bioeng Biotechnol. 2019;7:337.PubMedPubMedCentralCrossRef
171.
Chen P, Piao X, Bonaldo P. Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury. Acta Neuropathol. 2015;130:605–18.PubMedCrossRef
172.
Freeman MR. Signaling mechanisms regulating Wallerian degeneration. Curr Opin Neurobiol. 2014;27:224–31.PubMedCrossRef
173.
Ducic I, Yoon J, Buncke G. Chronic postoperative complications and donor site morbidity after sural nerve autograft harvest or biopsy. Microsurgery. 2020;40:710–6.PubMedPubMedCentralCrossRef
174.
175.
Abdullah M, O’Daly A, Vyas A, Rohde C, Brushart TM. Adult motor axons preferentially reinnervate predegenerated muscle nerve. Exp Neurol. 2013;249:1–7.PubMedCrossRef
176.
Barbour JR, Yee A, Moore AM, Trulock EP, Buchowski JM, Mackinnon SE. Cadaveric nerve allotransplantation in the treatment of persistent thoracid neuralgia. Ann Thoracic Surg. 2015;99:1414–7.CrossRef
177.
Larsen M, Habermann TM, Bishop AT, Shin AY, Spinner RJ. Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case Report. J Neurosurg. 2007;5:924–8.CrossRef
Metadata
Title
Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries
Authors
George D. Bittner
Jared S. Bushman
Cameron L. Ghergherehchi
Kelly C. S. Roballo
Jaimie T. Shores
Tyler A. Smith
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2022
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-022-02395-0

Other articles of this Issue 1/2022

Journal of Neuroinflammation 1/2022 Go to the issue

Research

Lung inflammation induced by silica particles triggers hippocampal inflammation, synapse damage and memory impairment in mice

Research

PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury

Research

A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease

Research

Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway

Research

Phagocytosis converts infiltrated monocytes to microglia-like phenotype in experimental brain ischemia

Research

Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner